Results

Total Results: 437 records

Showing results for "therapeutic".

  1. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
    March 01, 2020 - Introduction Anticoagulants are a critical therapy in the prevention and treatment of various types … Dabigatran versus Warfarin in the treatment of acute venous thromboembolism. … Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. … Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia. … The mean time of the INR in therapeutic range (TTR) was 62.75%.
  2. www.ahrq.gov/research/findings/ta/index.html
    May 01, 2025 - Ventilators (2017; PDF - 144 KB) Catheter Ablation for Atrial Fibrillation (2014; PDF - 216 KB) Therapeutic … Options for Obesity in the Medicare Population (2014; PDF - 316 KB) Pain Management Injection Therapies
  3. www.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-reimagining-healthcare-teams-2.html
    July 01, 2023 - a patient’s history or to consider all potential data points to develop high-quality diagnostic or therapeutic
  4. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Hurley_55.pdf
    March 07, 2008 - The grant supported the creation of the Community Anticoagulation Therapy (CAT) Clinic and the Cedar … These two practices manage approximately 2,000 patients on long-term warfarin therapy, representing … Therefore, almost 40 percent of the variation in a patient’s therapeutic range (typical therapeutic … Repeat INR determinations would be made until the patient was back in therapeutic range. … Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota
  5. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb-ger.pdf
    June 02, 2025 - to distinguish between physiologic and pathologic GER (GERD, or GER disease) before beginning any therapeuticTreatment ■ Medical or surgical therapy is indicated only for pathological GER. … ■ Therapies may improve symptoms, but generally reflux is not entirely eliminated.
  6. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-164-materials-ii.pdf
    June 02, 2025 - Services and Codes, by Severity Treatment Variables Definition – by Severity Variable Proc. … Partial Pulpectomy D7210, D7220, D7230, D7240 Complete Pulpectomy D3120 Pulp Cap Indirect D3220 Therapeutic … Pulpotomy D3240 Pulpal therapy Posterior Primary D3310 , D3320, D3330 End Therapy (Root Canals), Anterior … Bicuspid and Posterior Tooth ENDODONTICS D3120 Pulp Cap Indirect D3220 Therapeutic Pulpotomy D3240 … Pulpal therapy Posterior Primary End Therapy (Root Canals), Anterior Bicuspid and Posterior Tooth
  7. www.ahrq.gov/research/findings/final-reports/stpra/stpraapbfig3.html
    April 01, 2018 - and cataract procedures—30 percent Excision of semilunar cartilage of the knee—8 percent Other therapeutic
  8. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/improve/program-part1-slides.pptx
    November 01, 2019 - trends Assists with some AS interventions (non-stewardship pharmacists) IV to oral conversion protocols Therapeutic … antibiotic monitoring protocols Pharmacy and Therapeutics (P&T) Committee Decisions regarding formulary … Adverse event detection Appropriate microbiology specimen collection Timing of therapeutic drug level … Antibiotic Decision Making approach Diagnostic criteria for infection Appropriate cultures and empiric therapy … The ASP should develop guidelines for management and treatment of common infectious diseases syndromes
  9. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Emanuel-Berwick_110.pdf
    July 02, 2008 - simple and overarching model identifies four domains of patient safety (recipients of care, providers, therapeutics … In an important parallel development, as treatments became increasingly effective, the medical field … The practitioner was trained and certified to apply therapy at the point of the illness-causing disorder … Misuse was further defined as the preventable complications of treatment. … The nature of the illnesses and social setting, the nature of the therapies, the nature of the human
  10. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb-apnea.pdf
    June 02, 2025 - center in the immature brain stem does not trigger inspiration; frequently responds to methylxanthine treatment … Home Treatment ■ Most infants still having apnea are kept hospitalized; few may be discharged home. … – Caffeine is most commonly used due to its broader therapeutic index and slower excretion rate than … Infants are generally monitored for a 5- to 7-day apnea-free period after discontinuing methylxanthine therapy
  11. www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK2_T1-Concise_Antibiogram_Toolkit_Background.pdf
    May 01, 2014 - nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy … susceptibility test data reports to determine the most appropriate agents for initial empirical antimicrobial therapy … practitioners, and physician assistants—can consult these tools before initiating empiric antibiotic therapy …  Selection of empiric therapy in a particular patient should not be based solely on an antibiogram … including patient characteristics and prevalence of other risk factors should be incorporated when making therapeutic
  12. www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK2_T1-Concise_Antibiogram_Toolkit_Background.doc
    May 01, 2014 - nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy … susceptibility test data reports to determine the most appropriate agents for initial empirical antimicrobial therapy … practitioners, and physician assistants—can consult these tools before initiating empiric antibiotic therapy … · Selection of empiric therapy in a particular patient should not be based solely on an antibiogram … including patient characteristics and prevalence of other risk factors should be incorporated when making therapeutic
  13. www.ahrq.gov/research/findings/final-reports/stpra/stpraapb.html
    April 01, 2018 - Excision of semilunar cartilage of knee 67,742 2.38% 38,074 2.06% 29,668 2.95% Other therapeutic … Inguinal and femoral hernia repair 48,674 1.71% 40,790 2.21% 7,884 0.78% Other OR therapeutic
  14. www.ahrq.gov/funding/grantee-profiles/grtprofile-malone.html
    September 01, 2023 - The University had received a grant from the AHRQ Centers for Education and Research on Therapeutics … Specifically, he held focus groups with hospital pharmacy and therapeutic (P&T) committee members—whose
  15. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - ● Antipsychotic medications are among the most expensive, highest in risk, and fastest growing of therapeutic … Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental Health Therapeutics … The next measure encourages use of psychosocial intervention as a first-line treatment for children … Two measures assess receipt of services for children and adolescents who initiate antipsychotic treatment
  16. www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/iadapt/yelin.pdf
    December 19, 2014 - Project Aims The project aims were to: 1) Assess current knowledge of therapeutic options in
  17. www.ahrq.gov/sites/default/files/2024-01/lambert2-report.pdf
    January 01, 2024 - Final Progress Report: UIC Center for Education and Research on Therapeutics Tools for Optimizing Prescribing … Emphasis centers on the quality of the available evidence and on comparisons to therapeutic alternatives … specified the use of actual body weight for dosing and trough serum concentrations at steady state for therapeutic … The use of anticoagulant therapy for the prevention and treatment of venous thromboembolism (VTE) and … being used as a mechanism to switch otherwise reluctant patients from expensive to less expensive therapies
  18. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA116-Materials-II.pdf
    June 02, 2025 - Documentation child was eligible for and received therapeutic hypothermia (when appropriate). … EXCLUDE if identification of eligibility and plan for therapeutic hypothermia were in place within
  19. www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK1_T1-Background_final.docx
    October 01, 2016 - susceptibility test data reports to determine the most appropriate agents for initial empirical antimicrobial therapy … practitioners, and physician assistants—can consult these tools before initiating empiric antibiotic therapy … Antibiograms are not generalizable to different nursing homes; they can be useful tools for guiding empiric therapy … monitoring antibiotic susceptibility trends within a specific nursing home. · Selection of empiric therapy … including resident characteristics and prevalence of other risk factors should be incorporated when making therapeutic
  20. www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK1_T1-Background_final.pdf
    October 01, 2016 - susceptibility test data reports to determine the most appropriate agents for initial empirical antimicrobial therapy … practitioners, and physician assistants—can consult these tools before initiating empiric antibiotic therapy … Antibiograms are not generalizable to different nursing homes; they can be useful tools for guiding empiric therapy … • Selection of empiric therapy in a particular resident should not be based solely on an antibiogram … resident characteristics and prevalence of other risk factors should be incorporated when making therapeutic

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: